Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Issuances (2011 - 2014)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Long-Term Debt Issuances came in at -$280000.0 in Q4 2014, down 200.0% quarter-over-quarter from $280000.0 in Q3 2014.
Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Issuances (2011 - 2014) Analysis & Trends
Tonix Pharmaceuticals Holding's Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at -$280000.0 for Q4 2014.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$280000.0 in Q4 2014; TTM through Sep 2014 was $280000.0, a 58.21% decrease from a year earlier, with the FY2023 full-year figure at $8.9 million, changed N/A from the prior year.
- Long-Term Debt Issuances slipped to -$280000.0 in Q4 2014 per TNXP's latest filing, from $280000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $1.5 million in Q4 2011 and bottomed at -$280000.0 in Q4 2014.
- The 4-year median for Long-Term Debt Issuances is $240000.0 (2013), against an average of $361833.3.
- Across the five-year window, Long-Term Debt Issuances plunged 74.02% in 2012 and soared 250.0% in 2014, its largest moves.
- Year by year, Long-Term Debt Issuances stood at $1.5 million in 2011, then plunged by 74.02% to $390000.0 in 2012, then plunged by 79.49% to $80000.0 in 2013, then sank by 450.0% to -$280000.0 in 2014.
- Per Business Quant, the three latest TNXP Long-Term Debt Issuances figures stand at -$280000.0 (Q4 2014), $280000.0 (Q3 2014), and $80000.0 (Q3 2013).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 140.53 Mn | 140.53 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -280,000.00 |
| Dec 31, 2014 | -280,000.00 |
| Sep 30, 2014 | 280,000.00 |
| Sep 30, 2014 | 280,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Jun 30, 2013 | 200,000.00 |
| Jun 30, 2013 | 200,000.00 |
| Dec 31, 2012 | 390,000.00 |
| Dec 31, 2012 | 390,000.00 |
| Dec 31, 2011 | 1.50 Mn |
| Dec 31, 2011 | 1.50 Mn |